Chemed Co. (NYSE:CHE) Shares Sold by Iowa State Bank

Iowa State Bank decreased its holdings in Chemed Co. (NYSE:CHEFree Report) by 5.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 900 shares of the company’s stock after selling 50 shares during the quarter. Iowa State Bank’s holdings in Chemed were worth $526,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Fifth Third Bancorp raised its holdings in Chemed by 0.5% in the 3rd quarter. Fifth Third Bancorp now owns 3,914 shares of the company’s stock worth $2,034,000 after purchasing an additional 21 shares during the period. Legacy Wealth Asset Management LLC raised its holdings in Chemed by 0.9% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company’s stock worth $1,330,000 after purchasing an additional 21 shares during the period. Deutsche Bank AG raised its holdings in Chemed by 0.5% in the 1st quarter. Deutsche Bank AG now owns 4,893 shares of the company’s stock worth $2,631,000 after purchasing an additional 22 shares during the period. Kestra Advisory Services LLC raised its holdings in Chemed by 3.8% in the 3rd quarter. Kestra Advisory Services LLC now owns 634 shares of the company’s stock worth $329,000 after purchasing an additional 23 shares during the period. Finally, IHT Wealth Management LLC raised its holdings in Chemed by 3.8% in the 2nd quarter. IHT Wealth Management LLC now owns 624 shares of the company’s stock worth $338,000 after purchasing an additional 23 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Royal Bank of Canada upped their price target on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a report on Monday, March 4th. Oppenheimer increased their target price on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Thursday, February 29th.

Check Out Our Latest Stock Analysis on CHE

Insider Activity

In other news, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the sale, the executive vice president now directly owns 20,760 shares in the company, valued at $13,320,654. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CFO Michael D. Witzeman sold 2,650 shares of the stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $643.14, for a total value of $1,704,321.00. Following the completion of the transaction, the chief financial officer now directly owns 2,882 shares in the company, valued at $1,853,529.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the transaction, the executive vice president now owns 20,760 shares of the company’s stock, valued at $13,320,654. The disclosure for this sale can be found here. Insiders sold 15,808 shares of company stock worth $10,184,531 over the last ninety days. Corporate insiders own 3.80% of the company’s stock.

Chemed Stock Down 0.7 %

Shares of Chemed stock traded down $4.43 during mid-day trading on Tuesday, reaching $636.20. 59,310 shares of the stock traded hands, compared to its average volume of 81,056. The business has a 50-day moving average of $616.07 and a 200 day moving average of $579.61. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62. The stock has a market capitalization of $9.62 billion, a PE ratio of 35.50, a PEG ratio of 2.58 and a beta of 0.42.

Chemed (NYSE:CHEGet Free Report) last announced its earnings results on Tuesday, February 27th. The company reported $6.60 EPS for the quarter, beating analysts’ consensus estimates of $6.25 by $0.35. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The business had revenue of $585.90 million during the quarter, compared to analysts’ expectations of $586.64 million. During the same quarter in the prior year, the firm earned $5.39 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. On average, equities research analysts expect that Chemed Co. will post 21.99 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were given a $0.40 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.25%. Chemed’s dividend payout ratio (DPR) is presently 8.93%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.